The Devaluation of Otolaryngology: An Evaluation of CMS' Involvement in Physician Reimbursement
The Laryngoscope · 2025
DOI: 10.1002/lary.32170 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2025. Verfasst von R Peter Manes und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Otolaryngology, Department of Surgery, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Otolaryngology, Centers for Medicare and Medicaid Services, U.S., Relative Value Scales, Medicare. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate the rate at which the Relative Value Scale Update Committee (RUC) recommended relative value unit (RVU) values for otolaryngology procedures are accepted by the Centers for Medicare and Medicaid Services (CMS).
Methods
The Federal Register ( https://www.federalregister.gov ) was queried from 1995 to 2021 to identify the annual Medicare Final Rule. Within the Medicare Final Rule, all codes reviewed by the RUC were evaluated by two independent authors. Codes where the American Academy of Otolaryngology‐Head and Neck Surgery (AAOHNS) and/or the Triologic Society participated in the valuation were extracted.
Results
From 1995 to 2021, 271 codes relating to otolaryngology were surveyed and valued by the RUC. In 201 (74%) of those codes, CMS did not alter the RUC recommended value. CMS did alter the RUC recommended value of 70 (26%) codes. From 1995 to 2008, 91 otolaryngology codes were valued. Eighty (88%) of those values were not altered by CMS. Eleven (12%) values were altered by CMS in the Medicare Final Rule. From 2009 to 2021, 180 otolaryngology codes were valued. One hundred twenty‐one (67%) of those values were not altered by CMS. Fifty‐nine (33%) of those values were altered by CMS. The difference between the two time periods was significant ( p = 0.0002). The reduction by CMS throughout all codes ranged from 2% to 100%, with an average alteration of 5%.
Conclusion
CMS is taking an increasing role in altering RUC‐approved values for otolaryngology procedures. This has implications for both otolaryngology and all medical societies in terms of how their procedures are valued. Level of Evidence N/A.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Otolaryngology, Department of Surgery, Yale School of Medicine, New Haven, Connecticut, USA.
- Georgetown University Medical School, Washington, District of Columbia, USA.
ORCID-Profile: R Peter Manes
Zitieren
APA
Manes, R. P., & Vasandani, S. (2025). The Devaluation of Otolaryngology: An Evaluation of CMS' Involvement in Physician Reimbursement. The Laryngoscope. https://doi.org/10.1002/lary.32170
Vancouver
Manes RP, Vasandani S. The Devaluation of Otolaryngology: An Evaluation of CMS' Involvement in Physician Reimbursement. The Laryngoscope. 2025. doi:10.1002/lary.32170
BibTeX
@article{Manes2025,
author = {Manes, R Peter and Vasandani, Sagar},
title = {The Devaluation of Otolaryngology: An Evaluation of CMS' Involvement in Physician Reimbursement},
journal = {The Laryngoscope},
year = {2025},
doi = {10.1002/lary.32170}
}
EUVIMED